3,4-dihydroxyphenylacetic acid has been researched along with minocycline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miller, DB; O'Callaghan, JP; Sriram, K | 1 |
| Aoki, E; Araki, T; Kato, H; Yano, R; Yokoyama, H | 1 |
| Engle, EL; Graham, DR; Meulendyke, KA; Pletnikov, MV; Tarwater, PM; Zink, MC | 1 |
3 other study(ies) available for 3,4-dihydroxyphenylacetic acid and minocycline
| Article | Year |
|---|---|
Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Blotting, Western; Cell Count; Chemokine CCL2; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Glial Fibrillary Acidic Protein; Homovanillic Acid; Interleukin-6; Male; Methamphetamine; Mice; Mice, Mutant Strains; Microglia; Minocycline; Neurons; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Tyrosine 3-Monooxygenase | 2006 |
Comparative pharmacological study of free radical scavenger, nitric oxide synthase inhibitor, nitric oxide synthase activator and cyclooxygenase inhibitor against MPTP neurotoxicity in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipyrine; Cyclooxygenase Inhibitors; Dopamine; Edaravone; Enzyme Activators; Enzyme Inhibitors; Etodolac; Fatty Acids, Monounsaturated; Fluvastatin; Free Radical Scavengers; Homovanillic Acid; Indazoles; Indoles; Indomethacin; Male; Mice; Mice, Inbred C57BL; Minocycline; MPTP Poisoning; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Quinolines | 2008 |
Early minocycline treatment prevents a decrease in striatal dopamine in an SIV model of HIV-associated neurological disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; AIDS Dementia Complex; Animals; Blotting, Western; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Dopamine; Immunohistochemistry; Macaca; Minocycline; Neuroprotective Agents; Oxidative Stress; Reverse Transcriptase Polymerase Chain Reaction; Simian Acquired Immunodeficiency Syndrome | 2012 |